Breaking News on Pharmaceutical Technology

Product news > Drug delivery systems

Latest news headlines

Products

Suppliers

OptiNose gets $48.5m to take delivery device into Phase III

14-Jun-2010 - OptiNose is to take its nasal drug delivery device into Phase III using $48.5m (€40m) a private equity firm has agreed to invest in the business.

MonoSol and APR deal puts more drugs on film

10-Jun-2010 - MonoSol Rx and Applied Pharma Research have agreed to expand their working partnership to produce and market current prescription drug products in film form. This method of drug delivery has gained much momentum recently as an innovative and novel form of administering medication.

BD aims for convenience with smallest ever needle

09-Jun-2010 - Becton Dickinson (BD) is launching what could be the world’s smallest pen needle designed for insulin delivery. Patients in the United States will be the first recipients as BD aim to head up a market worth roughly $174bn (€145bn).

Philips and RXI partner to research RNAi delivery

07-Jun-2010 - Philips and RXi Pharmaceuticals have formed a research agreement to investigate combining their technologies for delivery of RNA interference (RNAi).

Financial climate better for potential delivery unit sale, says Elan

01-Jun-2010 - Irish pharmaceutical company Elan says most potential investors are positive about proposal to spin-off drug delivery unit.

Natural drug delivery system aids cancer therapeutics

01-Jun-2010 - New research could make it possible for scientists to use silicon particles as an effective drug delivery system that enables fragile small interfering RNA (siRNA) based drugs to be directly transported to the disease’s location.

Eisai opens manufacturing & development site at RTP

20-May-2010 - Eisai has opened a $100m (€81m), 65,000 sq ft commercial manufacturing and drug development site for intravenous treatments in Research Triangle Park (RTP), North Carolina, US.

Eurand cites Zenpep gains as key to Q1

17-May-2010 - Eurand says Zenpap important to Q1 growth that recent FDA move provides the drug with significant potential for further expansion in cystic fibrosis (CF) market

News in brief

3M launches nasal MDI with evaporating spray tech

17-May-2010 - 3M Drug Delivery Systems says new nasal MDI overcomes drip drawbacks using evaporating spray technology that can improve drug shelf-life.

Levitra, Herceptin combo used to target brain metastases

10-May-2010 - Administration of Levitra (vardenafil) can increase Herceptin (trastuzumab) delivery to brain metastases, but not surrounding healthy tissue, increasing survival in mice, according to research.

Antares and Uman team on RA drug delivery project

04-May-2010 - Rheumatoid arthritis (RA) sufferers may soon have a new treatment delivery option thanks to US delivery specialist Antares Pharma’s partnership with Canadian injectables specialist Uman Pharma.

Packaging drives West in Q1

04-May-2010 - Demand for high-tech packaging, H1N1 vaccine products and drug delivery technologies drove growth in Q1 says West Pharmaceutical Services.

EyeGate, GSK collaborate on ocular delivery of drugs

03-May-2010 - EyeGate Pharma is collaborating with GlaxoSmithKline (GSK) to evaluate the delivery if several of the big pharma’s therapies using an ocular delivery system.

Pro-Tect buys novel delivery tech patents for pain portffolio

29-Apr-2010 - Pro-Tect (PRTT) says new technology patents could drive “revolution” in once-daily drug delivery for pain meds.

Elan mulls hiving-off drug delivery business again

20-Apr-2010 - Irish drugmaker Elan has once again raised the possibility of selling its delivery business, Elan Drug Technologies (EDT).

BD to make 500m syringes a year in Hungary by 2015

15-Apr-2010 - Becton Dickinson (BD) says its new Hungarian plant will be operational this year and producing more than 500m pre-fillable glass syringes by 2015.

NuSil completes work on silicone facility

15-Apr-2010 - US firm NuSil Technology says new clean room manufacturing plant will help meet growing demand for silicone compounds for delivery systems.

Has Hospira beaten Myriad in Javelin competition?

13-Apr-2010 - US drugmaker Javelin Pharmaceuticals says Hospira’s takeover bid is “superior” and terminates agreement with Myriad Pharmaceuticals (MPI).

Alvogen signs up for Penwest’s Timerx tech

12-Apr-2010 - US delivery specialist Penwest is to apply its Timerx tech to “complex” generic pharmaceuticals in a development and commercialisation pact with non-branded drugmaker Alvogen.

Unilife starts 24/7 production after FDA marketing clearance

06-Apr-2010 - Unilife has initiated a 24/7 manufacturing cycle at its facility at Lewisberry, Pennsylvania, US after it received marketing clearance for its Unitract 1ml insulin syringes from the US FDA.

Antisense tech makes sense; Isis lands $1.5bn GSK accord

01-Apr-2010 - US firm Isis Pharmaceuticals could earn $1.5bn from its new antisense RNA drug development partnership with UK pharmaceutical major GSK.

Dainippon expands RNAi delivery deal with Silence Therapeutics

31-Mar-2010 - Silence Therapeutics says extension of RNAi drug delivery collaboration by Dainippon Sumitomo is evidence of technology’s potential.

RXi targets dermal cells with RNA delivery method

29-Mar-2010 - RXi Pharmaceuticals has applied its sd-rxRNA to dermal cells, establishing the efficacy of the technology as it seeks to move it on to the next stage of development, a company VP told in-PharmaTechnologist.

Inhalable delivery tech worth $38bn, says GIA

24-Mar-2010 - The increasing incidence of chronic and “lifestyle” related disorders will fuel demand for inhalable delivery technologies over the next five years, according to a Global Industry Analysts (GIA) report.

Compugen creates system to predict peptide delivery

17-Mar-2010 - Compugen has developed a computer-based, in silico system which can assist drug delivery research by identifying peptides that have the potential to penetrate cell membranes.

Sign up for your free newsletter